, particularly factors associated with brain
invasion and heightened recurrence rates, which remain elusive
, such as intratumoral hemorrhage, tumor
invasion into arterial and venous sinuses, leptomeningeal infiltration
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) methods frequently fall short, underscoring the imperative for non-
invasive alternatives. Non-coding RNAs
, such as therapeutic targets and non-
invasive diagnostic/prognostic biomarker tools. © 2024, The Author(s).
Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) , angiogenesis, inflammation, migration,
invasion and metastasis, epithelial-mesenchymal transition and others
Wang, Chunlei,
Beylerli, Ozal,
Gu, Yan,
Xu, Shancai,
Ji, Zhiyong,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Chekhonin, Vladimir (2024) in the development,
invasion, or recurrence of glioblastoma. Conclusion: The identification of DEGs and key genes